Page last updated: 2024-09-03

imatinib mesylate and Infective Endocarditis

imatinib mesylate has been researched along with Infective Endocarditis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutyra, M; Kozák, J; Lukl, J; Szotkowski, T; Táborský, M; Václavík, J1

Other Studies

1 other study(ies) available for imatinib mesylate and Infective Endocarditis

ArticleYear
Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.
    American journal of hematology, 2010, Volume: 85, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Benzamides; Drug Therapy, Combination; Endocarditis; Eosinophils; Heart; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Thrombosis; Treatment Outcome; Warfarin

2010